Urticarial vasculitis after meningococcal serogroup B vaccine in a 6 ‐year‐old girl

Abstract
The first vaccine that shows significant potential in providing broad coverage against serogroup B meningococcal disease has recently been approved. Because of its newness, potential adverse events need to be reported. Here we report a case of urticarial vasculitis, a rare disease in children, in probable relationship with the novel vaccine.

Source: Pediatric Dermatology - November 21, 2017 Category: Dermatology Authors: Virginia Velasco ‐Tamariz, Marta Prieto‐Barrios, Fátima Tous‐Romero, Sara Isabel Palencia‐Pérez, Concepción Postigo‐Llorente Tags: BRIEF REPORT Source Type: research